Wire · regulatory
FDA seeks feedback on framework for regulating GenAI devices
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 25 August 2026 · Fusion42 review
The FDA is seeking public feedback on a new competency-based framework to regulate medical devices using generative AI, focusing on evaluating the final user-facing device rather than underlying AI components. This aims to balance innovation and patient safety by adapting medical licensure concepts to AI device regulation, with comments due by October 19, 2026.
This Wire brief sits within Fusion42's coverage of Medtech, and 14 sources have reported it between 18 Aug 2026 and 24 Aug 2026.
◆ ◆ The Wire takeaway
The FDA is remaking medical device rules for generative AI based on clinical credentialing methods, opening a new compliance route for AI startups in health. You must prepare for this more complex evaluation that tests your device as a whole, not just its AI core.
◆ Coverage
14 sources · first reported 18 Aug 2026 · latest 24 Aug 2026
◆ Related on Wire
◆ Topics